Brookings Roundtable on Active Medical Product Surveillance: Monitoring the Safety of the 2009 H1N1 Influenza Vaccine in Near-Real Time: Learnings from PRISM
Past Event
Monitoring the Safety of the 2009 H1N1 Influenza Vaccine in Near-Real Time: Learnings from PRISM
On October 22, the Engelberg Center for Health Care Reform hosted a roundtable webinar, “Monitoring the Safety of the 2009 H1N1 Influenza Vaccine in Near Real-Time: Learnings from PRISM.”
The roundtable featured presentations from key experts on lessons learned from the implementation of the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) project, a coordinated federal strategy to monitor the safety of the 2009 H1N1 influenza vaccine using observational data from large health plans. Presenters provided an overview of PRISM and project conclusions, and described technical findings related to data infrastructure and methodological approaches. Discussion also focused on plans to integrate PRISM with the Mini-Sentinel active surveillance system.
Agenda
Welcome and Introduction
Mark B. McClellan
Former Brookings Expert
Director, Margolis Center for Health Policy - Duke University
HHS Rapid Response to a Public Health Need: H1N1 Vaccine Safety Surveillance
Dan Salmon
National Vaccine Program Office, U.S. Department of Health and Human Services
Data Infrastructure and Methodological Lessons Learned from PRISM
Richard Platt
Professor and Chair, Department of Population Medicine - Harvard Pilgrim Health Care Institute
Next Steps for Vaccine Safety Surveillance
Robert Ball
Deputy Director of the Office of Surveillance and Epidemiology - U.S. Food and Drug Administration
More Information
To subscribe or manage your subscriptions to our top event topic lists, please visit our event topics page.
